Gly-Med Life Sciences Private Limited
About Gly-Med Life Sciences Private Limited
Data last updated:
Gly-Med Life Sciences Private Limited is a private limited company based in Thrissur, Kerala, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 11 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U74990KL2018PTC055877. Its GSTIN is 32AAHCG5882A1ZU (Kerala).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7 Lakh. It is led by directors Sowmya and Mullakkal Kannan Velu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at II / 1220 Hari Nagar 7th Street Punkunnam, Thrissur, Kerala, India – 680002.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.35 Lakh, a decline of 53% compared to the previous year. For the same year it recorded a net loss of ₹2.41 Lakh (net margin -55.4%) and EBITDA of -₹2.35 Lakh (EBITDA margin -54%). Revenue has declined at a compounded annual rate (CAGR) of 30% over three years and 9% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Gly-Med Life Sciences Private Limited's registered office is in Thrissur, Kerala. Its e-mail address is in the company report.
- Email
- Registered AddressII / 1220 Hari Nagar 7th Street Punkunnam, Thrissur, Kerala, India – 680002
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Gly-Med Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Gly-Med Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Gly-Med Life Sciences Private Limited, buy the company report.
Financials of Gly-Med Life Sciences Private Limited
FY 2025 filings availableGly-Med Life Sciences Private Limited reported revenue of ₹4.35 Lakh (down 53% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 9% over five years, including a 53% fall in the latest year. EBITDA fell 69% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.35 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.41 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -54% | ||||
| Net Profit Margin | -55.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gly-Med Life Sciences Private Limited, buy the company report.
Board of directors of Gly-Med Life Sciences Private Limited
Gly-Med Life Sciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sowmya | Director | 23 Mar 2021 | 5 Years 7 Months | Current |
| Mullakkal Kannan Velu | Director | 29 Apr 2024 | 2 Years 6 Months | Current |
Peer comparison
Gly-Med Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amudan Chemicals Private Limited | ₹4.36 Lakh (FY 2025) | -92.0% | Kalyan, Maharashtra, India | |||
| Janitra Medicorp Private Limited | ₹4.36 Lakh (FY 2022) | 16.0% | Agra, Uttar Pradesh, India | |||
| Vaikai Agro Chemicals Private Limited | ₹4.36 Lakh (FY 2025) | 3.0% | Salem, Tamil Nadu, India | |||
| Dhoori Herbal (OPC) Private Limited | ₹4.35 Lakh (FY 2024) | -15.0% | Ranchi, Jharkhand, India | |||
| Decora Coatings Private Limited | ₹4.35 Lakh (FY 2024) | 52.0% | Rajkot, Gujarat, India | |||
| Gly-Med Life Sciences Private Limitedthis company | ₹4.35 Lakh (FY 2025) | -₹2.41 Lakh | -55.4% | -53.0% | Thrissur, Kerala, India | |
| Markus Pharmaceuticals Private Limited | ₹4.35 Lakh (FY 2023) | Alappuzha, Kerala, India | ||||
| Osaki Products Private Limited | ₹4.34 Lakh (FY 2018) | -55.0% | Madurai, Tamil Nadu, India | |||
| Ti GTM Trading India Private Limited | ₹4.33 Lakh (FY 2024) | Sojat, Rajasthan, India | ||||
| Sgi Corp Private Limited | ₹4.33 Lakh (FY 2017) | -48.0% | Mumbai, Maharashtra, India | |||
| Solray Nutras Private Limited | ₹4.3 Lakh (FY 2024) | 42900.0% | Mysore, Karnataka, India |
To see the full peer comparison of Gly-Med Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Gly-Med Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gly-Med Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Gly-Med Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAHCG5882A1ZU | Kerala | Active | 06 Mar 2019 |
To see the full GST registrations and return filing status of Gly-Med Life Sciences Private Limited, buy the company report.
Recent activity
Gly-Med Life Sciences Private Limited has 5 board changes on record since 2021: 2 appointments and 3 cessations. The latest: Mullakkal Kannan Velu was appointed as Director on 29 Apr 2024.
Frequently asked questions
Gly-Med Life Sciences is an active private limited company based in Thrissur, Kerala, India. The company works in other services, within the business services industry. It was incorporated on 11 December 2018 (8+ years old) and is registered under CIN U74990KL2018PTC055877.
Gly-Med Life Sciences has 2 current directors:
- Sowmya - Director
- Mullakkal Kannan Velu - Director
The latest financial statements of Gly-Med Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Gly-Med Life Sciences is 32AAHCG5882A1ZU, registered in Kerala.
The CIN (Corporate Identification Number) of Gly-Med Life Sciences is U74990KL2018PTC055877. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gly-Med Life Sciences was incorporated on 11 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Gly-Med Life Sciences by revenue are Amudan Chemicals Private Limited, Janitra Medicorp Private Limited, Vaikai Agro Chemicals Private Limited, Dhoori Herbal (OPC) Private Limited, Decora Coatings Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mullakkal Kannan Velu was appointed as Director on 29 Apr 2024. Praveen Anedath ceased to be Director on 29 Apr 2024. Sowmya ceased to be Additional Director on 30 Nov 2021. Gly-Med Life Sciences has 5 board changes on record in total.
The registered office of Gly-Med Life Sciences is at II 1220 Hari Nagar 7th Street Punkunnam, Thrissur, Kerala, India – 680002.
Gly-Med Life Sciences operates in the business services industry, in the other services segment.
The compliance status of Gly-Med Life Sciences is compliant as of 25 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
